Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results
/in Hyperthermia, International Publications /von 2009-04-01 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Apr;73(5):1538-44Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium
/in Hyperthermia, International Publications /von 2009-03-11 / Cancer Chemother. Pharmacol. 2009 Nov;64(6):1079-83Strong synergy of heat and modulated electromagnetic field in tumor cell killing
/in Hyperthermia, International Publications /von 2009-02-25 / Strahlenther Onkol 2009 Feb;185(2):120-6Hyperthermia as an adjunctive treatment for soft-tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2009-02-01 / Expert Rev Anticancer Ther 2009 Feb;9(2):199-210Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
/in Hyperthermia, International Publications /von 2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-47Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
/in Hyperthermia, International Publications /von 2009-01-15 / Cancer 2009 Jan;115(2):311-23Oncothermia treatment of cancer: from the laboratory to clinic
/in Hyperthermia, International Publications /von 2009-01-01 / Electromagn Biol Med 2009;28(2):148-65The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
/in Hyperthermia, International Publications /von 2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-402Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study
/in Hyperthermia, International Publications, Ovarian Cancer /von 2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de